Analyst / Firm | Company | Price | Rating | Price Target | Upside/Downside | Date |
---|---|---|---|---|---|---|
Travere Therapeutics IncTVTX | $13.48 | Strong Buy | $23.00 | +70.62% | 14 hours ago | |
Analyst RankingTop 23% #1061 out of 4671 analysts Average Return+2.29% Win Rate43%69 out of 162 Risk vs RewardPoor Good Analyst ColorJP Morgan's Anupam Rama raised their price target on Travere Therapeutics (NASDAQ: TVTX) by 15% from $20 to $23 on 2024/09/13. The analyst maintained their Strong Buy rating on the stock. Rama said their price target move reflected updates to JP Morgan's models in the Smid-cap biotechnology space. | ||||||
Tesla IncTSLA | $800.00 | Strong Buy | $850.00 | +6.25% | a day ago | |
Upgrade to Premium to View MoreStrong buys: Upgrade to Premium to view the rest of today's Strong Buy stocks from Wall Street's top analysts Already have a premium account? Sign In |